SCOTUS and Judge Kacsmaryk force us to pose the question: Where did it all go wrong?
prescription drugs
Posted inHealth and Social Policy
India Decides Fighting Tuberculosis Is More Important Than Johnson & Johnson’s Profits
The country shot down a patent extension on a critical TB drug.
Posted inHealth and Social Policy
California Goes In for Drugmaking
The state will make and distribute insulin at cost. That should be a model for every other state.
Posted inTAP
A Big Miss on Drug Prices
Today on Tap: President Biden’s NIH rejects a petition to seize the patent of an unaffordable prescription drug.
Posted inPolitics
The American Rescue Plan’s Hidden Triumphs
Medicaid expansion in North Carolina and Eli Lilly’s insulin price cuts are largely due to the March 2021 law.
Posted inTAP
A Small Victory Over Big Pharma
Today on TAP: Eli Lilly announces insulin price caps, but keep an eye on the footnotes.
Posted inHealth and Social Policy
Private Health Care Companies Are Eating the American Economy
A new report from Wendell Potter at the Center for Health and Democracy examines just how the private insurance market makes its money—and how American health care is worse off for it.
Posted inEconomic Policy
Breaking Up (With China) Is Hard to Do
In the absence of more attention to the supply chain, the U.S. is becoming even more reliant on Beijing—and ‘friendshoring’ often increases that dependence.
Posted inPolitics
Mr. Sanders Goes Away From Washington
The new chair of the Senate HELP Committee plans to hold numerous field hearings to bring attention to issues in health care, labor, and education.
Posted inTAP
Attacking the ‘You Are the Product’ Economy
Today on TAP: The FTC takes action against GoodRx for sharing personal health data with advertisers.